Skip to main content
. 2021 Apr 18;13(8):1947. doi: 10.3390/cancers13081947

Figure 1.

Figure 1

Distribution of clinically relevant variants of significantly mutated genes in 60 MDS/CMML cases. Pathogenic and likely pathogenic variants (SNVs and indels) identified in 28 out of the 40 genes analyzed are shown. Of the 60 samples evaluated, 54 (90%) had at least one mutation in one of the listed genes. The WHO 2016 classification, the cytogenetic risk, the IPSS-R or CPSS category, and the number of blasts for each patient are shown at the top of the chart. The color of the mutation depends on its functional type. The heatmap was made with the OncoPrinter tool (https://www.cbioportal.org/visualize, accessed on: 10 April 2021).